The present invention comprises methods for reducing plasma lipids, plasma free fatty acids (FFA), plasma glycerol and triglycerides in a mammal through the administration of certain substituted cyclopropane acid derivatives of Formula 1: ##STR00001## wherein R1-R6 are defined herein and pharmaceutical compositions comprising them.